A COVID-19 Vaccine Could Crush These 3 Tech Stocks
The COVID-19 crisis has crushed many stocks over the past year, but it also lit a fire under stay-at-home stocks that benefited from social distancing measures and the growing usage of online services. But over the past month, Pfizer and Moderna revealed two vaccines that were more than 90% effective at preventing COVID-19.
Neither vaccine has been approved by the Food and Drug Administration (FDA) yet, but the headlines caused many investors to scurry out of stay-at-home stocks and toward battered sectors like travel and retail in hopes of capitalizing on a post-pandemic recovery.
Investors shouldn't blindly follow that herd, but they should recognize the companies whose stocks could crumble if the vaccines are approved. Let's look at three such stocks that stand to lose if a vaccine if fully approved.
Source Fool.com
